Click to view
Osteoarthritis affects an estimated 80% of geriatric dogs, and once cartilage begins to break down, there is no cure; only management. Sady Tarek's thesis for the London College of Animal Osteopathy asks a practical question: where does osteopathic manual therapy actually fit alongside the pharmacological treatments that dominate current veterinary practice, and what does the evidence say about combining the two? The stakes are far from academic. NSAIDs remain the cornerstone of OA management, and newer options like anti-NGF monoclonal antibodies have expanded what's possible for dogs with comorbidities or contraindications to standard drugs. But medication controls pain and inflammation without repairing the joint, and owners are increasingly turning to hands-on therapies expecting results the evidence hasn't yet fully confirmed. Understanding what manual therapy can and cannot deliver, and where it genuinely helps shapes real treatment decisions for real dogs. Tarek's analysis draws on canine, equine and human osteoarthritis literature, since direct evidence for manual therapy in dogs remains limited. It traces how mobilization and manipulation techniques act biomechanically and neurophysiologically, and sets their documented effects, including findings from horses, where a single manipulative treatment outperformed both massage and phenylbutazone for chronic back pain — against the trial evidence already established for NSAIDs and nutraceuticals in dogs.
.png)
.png)
